Xia Liu

2.4k total citations
61 papers, 1.9k citations indexed

About

Xia Liu is a scholar working on Molecular Biology, Neurology and Endocrine and Autonomic Systems. According to data from OpenAlex, Xia Liu has authored 61 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Molecular Biology, 14 papers in Neurology and 9 papers in Endocrine and Autonomic Systems. Recurrent topics in Xia Liu's work include Neurological Disease Mechanisms and Treatments (6 papers), Vagus Nerve Stimulation Research (5 papers) and MicroRNA in disease regulation (5 papers). Xia Liu is often cited by papers focused on Neurological Disease Mechanisms and Treatments (6 papers), Vagus Nerve Stimulation Research (5 papers) and MicroRNA in disease regulation (5 papers). Xia Liu collaborates with scholars based in China, United States and Canada. Xia Liu's co-authors include Ding‐Feng Su, Yang Sun, Ding‐Feng Su, Yili Yang, Huan Gui, Yang Sun, Sandeep Sood, Hattie Liu, Richard L. Horner and Zhen Qin and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and SHILAP Revista de lepidopterología.

In The Last Decade

Xia Liu

56 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xia Liu China 24 692 311 272 268 236 61 1.9k
Antoine Coquerel France 23 600 0.9× 235 0.8× 164 0.6× 173 0.6× 149 0.6× 81 1.9k
María García‐Fernández Spain 29 1.2k 1.8× 188 0.6× 258 0.9× 301 1.1× 82 0.3× 90 2.4k
David Engblom Sweden 32 1.1k 1.6× 123 0.4× 393 1.4× 485 1.8× 454 1.9× 74 3.7k
Yahong Zhang China 23 543 0.8× 267 0.9× 107 0.4× 136 0.5× 84 0.4× 56 1.8k
Sheng Wang China 26 660 1.0× 142 0.5× 625 2.3× 305 1.1× 102 0.4× 129 2.2k
Marong Fang China 26 844 1.2× 386 1.2× 69 0.3× 285 1.1× 492 2.1× 105 2.2k
Vladimir N. Chubarev Russia 21 1.0k 1.5× 210 0.7× 71 0.3× 338 1.3× 165 0.7× 57 2.3k
Yali Wang China 27 634 0.9× 77 0.2× 185 0.7× 465 1.7× 281 1.2× 110 2.4k

Countries citing papers authored by Xia Liu

Since Specialization
Citations

This map shows the geographic impact of Xia Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xia Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xia Liu more than expected).

Fields of papers citing papers by Xia Liu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xia Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xia Liu. The network helps show where Xia Liu may publish in the future.

Co-authorship network of co-authors of Xia Liu

This figure shows the co-authorship network connecting the top 25 collaborators of Xia Liu. A scholar is included among the top collaborators of Xia Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xia Liu. Xia Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gao, Nana, et al.. (2025). Cryptotanshinone alleviates cerebral ischemia reperfusion injury by regulating ferroptosis through the PI3K/AKT/Nrf2 and SLC7A11/GPX4 signaling pathway. Journal of Ethnopharmacology. 348. 119800–119800. 2 indexed citations
2.
Xiao, Peng, Zhehang Chen, Wenhao Xia, et al.. (2025). Targeting hyaluronan synthesis enhances the therapeutic effectiveness of biologics in inflammatory bowel disease. JCI Insight. 10(1).
3.
Liu, Xia, et al.. (2025). Antifreeze peptides from Channa argus skin: Structural characterization and cryoprotective efficacy of peptide TA-14. Food Bioscience. 72. 107552–107552. 1 indexed citations
4.
Cao, Jiamin, Liping Zhu, Wei‐Cai Zeng, et al.. (2025). Endophytic fungus MH397503 mediates the structural modification of agarwood chromones and its anti-vascular endothelial injury activity. Fitoterapia. 187. 106872–106872.
5.
Sun, Yang, Jing Yang, Yi Chen, et al.. (2025). Deficiency of hepatokine orosomucoid1 aggravates NAFLD progression in mice. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1871(3). 167654–167654. 2 indexed citations
6.
Jing, Kai, Feng Chen, Jingjing Wan, et al.. (2024). Orosomucoid 2 is an endogenous regulator of neuronal mitochondrial biogenesis and promotes functional recovery post-stroke. Pharmacological Research. 209. 107422–107422. 3 indexed citations
7.
Chen, Fei, Zhen Zhang, Huimin Zhang, et al.. (2024). Activation of α7 Nicotinic Acetylcholine Receptor Improves Muscle Endurance by Upregulating Orosomucoid Expression and Glycogen Content in Mice. Journal of Cellular Biochemistry. 125(9). e30630–e30630. 1 indexed citations
8.
9.
Wan, Jingjing, Zhen Zhang, Sai Tian, et al.. (2022). Single cell study of cellular diversity and mutual communication in chronic heart failure and drug repositioning. Genomics. 114(3). 110322–110322. 12 indexed citations
10.
Qin, Zhen, et al.. (2020). Energy Metabolism in Exercise-Induced Physiologic Cardiac Hypertrophy. Frontiers in Pharmacology. 11. 1133–1133. 15 indexed citations
11.
Hou, Xiaodan, Zhixue Wang, Fang Ding, et al.. (2019). Taurine Transporter Regulates Adipogenic Differentiation of Human Adipose-Derived Stem Cells through Affecting Wnt/β-catenin Signaling Pathway. International Journal of Biological Sciences. 15(5). 1104–1112. 13 indexed citations
12.
Yu, Jian‐Guang, et al.. (2019). Anisodamine Ameliorates Hyperkalemia during Crush Syndrome through Estradiol-Induced Enhancement of Insulin Sensitivity. Frontiers in Pharmacology. 10. 1444–1444. 10 indexed citations
13.
Z., Oak, Geza Kiss, Scott J. Mellender, Xia Liu, & Harvey R. Weiss. (2017). Rapamycin decreased blood-brain barrier permeability in control but not in diabetic rats in early cerebral ischemia. Neuroscience Letters. 654. 17–22. 10 indexed citations
14.
Z., Oak, et al.. (2016). Hypoxic Preconditioning Increases Blood-Brain Barrier Disruption in the Early Stages of Cerebral Ischemia. Current Neurovascular Research. 14(1). 26–31. 12 indexed citations
15.
Zhang, Enhui, Miao Wu, Jin‐Min Guo, et al.. (2016). Activation of α7 Nicotinic Acetylcholine Receptor Decreases On-site Mortality in Crush Syndrome through Insulin Signaling-Na/K-ATPase Pathway. Frontiers in Pharmacology. 7. 79–79. 17 indexed citations
16.
Sun, Yang, et al.. (2015). An updated role of microRNA-124 in central nervous system disorders: a review. Frontiers in Cellular Neuroscience. 9. 193–193. 184 indexed citations
17.
Gui, Huan, Xia Liu, Lirong Liu, Ding‐Feng Su, & Sheng‐Ming Dai. (2014). Activation of cannabinoid receptor 2 attenuates synovitis and joint distruction in collagen-induced arthritis. Immunobiology. 220(6). 817–822. 48 indexed citations
18.
Sun, Yang, Qi Li, Huan Gui, et al.. (2013). MicroRNA-124 mediates the cholinergic anti-inflammatory action through inhibiting the production of pro-inflammatory cytokines. Cell Research. 23(11). 1270–1283. 213 indexed citations
19.
Li, Qi, Lei Hong, Aijun Liu, et al.. (2011). The antishock effect of anisodamine requires the upregulation of α7 nicotine acetylcholine receptors by IL-10. Life Sciences. 89(11-12). 395–401. 12 indexed citations
20.
Liu, Xia, Yongliang Zhang, Yizhi Yu, Xiao Yang, & Xuetao Cao. (2007). SOCS3 promotes TLR4 response in macrophages by feedback inhibiting TGF-β1/Smad3 signaling. Molecular Immunology. 45(5). 1405–1413. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Antoine Coquerel Breakdown of academic impact, for papers by María García‐Fernández Breakdown of academic impact, for papers by David Engblom Breakdown of academic impact, for papers by Yahong Zhang Breakdown of academic impact, for papers by Sheng Wang Breakdown of academic impact, for papers by Marong Fang Breakdown of academic impact, for papers by Vladimir N. Chubarev Breakdown of academic impact, for papers by Yali Wang
Rankless by CCL
2026